These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25824337)

  • 1. 1α,25-Dihydroxyvitamin D3 Inhibits Esophageal Squamous Cell Carcinoma Progression by Reducing IL6 Signaling.
    Chen PT; Hsieh CC; Wu CT; Yen TC; Lin PY; Chen WC; Chen MF
    Mol Cancer Ther; 2015 Jun; 14(6):1365-75. PubMed ID: 25824337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-6-stimulated CD11b+ CD14+ HLA-DR- myeloid-derived suppressor cells, are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus.
    Chen MF; Kuan FC; Yen TC; Lu MS; Lin PY; Chung YH; Chen WC; Lee KD
    Oncotarget; 2014 Sep; 5(18):8716-28. PubMed ID: 25238263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of vitamin D3 in tumor aggressiveness and radiation response for hepatocellular carcinoma.
    Chen PT; Hsieh CC; Chen MF
    Mol Carcinog; 2022 Aug; 61(8):787-796. PubMed ID: 35611989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-6 expression predicts treatment response and outcome in squamous cell carcinoma of the esophagus.
    Chen MF; Chen PT; Lu MS; Lin PY; Chen WC; Lee KD
    Mol Cancer; 2013 Apr; 12():26. PubMed ID: 23561329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-6/STAT3/TWIST inhibition reverses ionizing radiation-induced EMT and radioresistance in esophageal squamous carcinoma.
    Zang C; Liu X; Li B; He Y; Jing S; He Y; Wu W; Zhang B; Ma S; Dai W; Li S; Peng Z
    Oncotarget; 2017 Feb; 8(7):11228-11238. PubMed ID: 28061440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autocrine IL6-Mediated Activation of the STAT3-DNMT Axis Silences the TNFα-RIP1 Necroptosis Pathway to Sustain Survival and Accumulation of Myeloid-Derived Suppressor Cells.
    Smith AD; Lu C; Payne D; Paschall AV; Klement JD; Redd PS; Ibrahim ML; Yang D; Han Q; Liu Z; Shi H; Hartney TJ; Nayak-Kapoor A; Liu K
    Cancer Res; 2020 Aug; 80(15):3145-3156. PubMed ID: 32554751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL6 derived from cancer-associated fibroblasts promotes chemoresistance via CXCR7 in esophageal squamous cell carcinoma.
    Qiao Y; Zhang C; Li A; Wang D; Luo Z; Ping Y; Zhou B; Liu S; Li H; Yue D; Zhang Z; Chen X; Shen Z; Lian J; Li Y; Wang S; Li F; Huang L; Wang L; Zhang B; Yu J; Qin Z; Zhang Y
    Oncogene; 2018 Feb; 37(7):873-883. PubMed ID: 29059160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
    Zhang Y; Du XL; Wang CJ; Lin DC; Ruan X; Feng YB; Huo YQ; Peng H; Cui JL; Zhang TT; Wang YQ; Zhang H; Zhan QM; Wang MR
    Gastroenterology; 2012 Mar; 142(3):521-530.e3. PubMed ID: 22108192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressor of cytokine signaling-1 gene therapy induces potent antitumor effect in patient-derived esophageal squamous cell carcinoma xenograft mice.
    Sugase T; Takahashi T; Serada S; Nakatsuka R; Fujimoto M; Ohkawara T; Hara H; Nishigaki T; Tanaka K; Miyazaki Y; Makino T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Kishimoto T; Mori M; Doki Y; Naka T
    Int J Cancer; 2017 Jun; 140(11):2608-2621. PubMed ID: 28233302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plantamajoside inhibits lipopolysaccharide-induced epithelial-mesenchymal transition through suppressing the NF-κB/IL-6 signaling in esophageal squamous cell carcinoma cells.
    Li X; Chen D; Li M; Gao X; Shi G; Zhao H
    Biomed Pharmacother; 2018 Jun; 102():1045-1051. PubMed ID: 29710521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation decreases the Bin1 tumor suppressor in ESCC and restoration by decitabine inhibits the epithelial mesenchymal transition.
    Wang X; Wang J; Jia Y; Wang Y; Han X; Duan Y; Lv W; Ma M; Liu L
    Oncotarget; 2017 Mar; 8(12):19661-19673. PubMed ID: 28152502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation-induced myeloid-derived suppressor cells associated with squamous cell carcinoma of the head and neck.
    Chen WC; Lai CH; Chuang HC; Lin PY; Chen MF
    Head Neck; 2017 Feb; 39(2):347-355. PubMed ID: 27696591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoalantolactone Inhibits Esophageal Squamous Cell Carcinoma Growth Through Downregulation of MicroRNA-21 and Derepression of PDCD4.
    Wen SW; Zhang YF; Li Y; Xu YZ; Li ZH; Lü H; Zhu YG; Liu ZX; Tian ZQ
    Dig Dis Sci; 2018 Sep; 63(9):2285-2293. PubMed ID: 29781054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of ALDH1 in the prognosis of esophageal cancer and its relationship with tumor microenvironment.
    Chen MF; Chen PT; Lu MS; Chen WC
    Mol Carcinog; 2018 Jan; 57(1):78-88. PubMed ID: 28888039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RACK1 predicts poor prognosis and regulates progression of esophageal squamous cell carcinoma through its epithelial-mesenchymal transition.
    Wang N; Liu F; Cao F; Jia Y; Wang J; Ma W; Tan B; Wang K; Song Q; Cheng Y
    Cancer Biol Ther; 2015; 16(4):528-40. PubMed ID: 25719728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-627 mediates the epigenetic mechanisms of vitamin D to suppress proliferation of human colorectal cancer cells and growth of xenograft tumors in mice.
    Padi SK; Zhang Q; Rustum YM; Morrison C; Guo B
    Gastroenterology; 2013 Aug; 145(2):437-46. PubMed ID: 23619147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent biological targeting therapy of squamous cell carcinoma of the esophagus with cetuximab and trastuzumab.
    Yamazaki M; Yamashita Y; Kubo N; Yashiro M; Ohira M; Ako E; Tanaka H; Muguruma K; Sawada T; Hirakawa K
    Oncol Rep; 2012 Jul; 28(1):49-54. PubMed ID: 22562413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.
    Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY
    Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porphyromonas gingivalis promotes tumor progression in esophageal squamous cell carcinoma.
    Chen MF; Lu MS; Hsieh CC; Chen WC
    Cell Oncol (Dordr); 2021 Apr; 44(2):373-384. PubMed ID: 33201403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-125a-5p enhances the sensitivity of esophageal squamous cell carcinoma cells to cisplatin by suppressing the activation of the STAT3 signaling pathway.
    Zhao Y; Ma K; Yang S; Zhang X; Wang F; Zhang X; Liu H; Fan Q
    Int J Oncol; 2018 Aug; 53(2):644-658. PubMed ID: 29767234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.